Cargando…

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?

Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-line therapy for newly diagnosed individuals with type 2 diabetes (T2D) in management algorithms and guidelines after the UK Prospective Diabetes Study (UKPDS) showed cardiovascular mortality benefits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Ehtasham, Sargeant, Jack A., Zaccardi, Francesco, Khunti, Kamlesh, Webb, David R., Davies, Melanie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761522/ https://www.ncbi.nlm.nih.gov/pubmed/33261058 http://dx.doi.org/10.3390/ph13120427

Ejemplares similares

Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
por: Sargeant, Jack A., et al.
Publicado: (2020)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

The Effects of Omega-3 Supplementation on Depression in Adults with Cardiometabolic Disease: A Systematic Review of Randomised Control Trials
por: Arsenyadis, Franciskos, et al.
Publicado: (2022)

Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
por: Kar, Debasish, et al.
Publicado: (2016)

Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
por: Zaccardi, Francesco, et al.
Publicado: (2020)

Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates
por: Zaccardi, Francesco, et al.
Publicado: (2018)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
por: Ling, Suping, et al.
Publicado: (2023)

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
por: Zaccardi, Francesco, et al.
Publicado: (2016)

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
por: Vetrone, Lorenzo M., et al.
Publicado: (2018)

Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020)

Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England
por: Abner, Sophia, et al.
Publicado: (2022)

The importance of physical activity in management of type 2 diabetes and COVID-19
por: Seidu, Samuel, et al.
Publicado: (2021)

Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017
por: Lawson, Claire A., et al.
Publicado: (2019)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
por: Hussein, Humaira, et al.
Publicado: (2018)

Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion
por: Barker, Mary M., et al.
Publicado: (2023)

Serum Potassium and Glucose Regulation in the ADDITION-Leicester Screening Study
por: Carter, Patrice, et al.
Publicado: (2015)

Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis
por: Barker, Mary M, et al.
Publicado: (2022)

A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
por: Sargeant, Jack Alistair, et al.
Publicado: (2019)

Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study
por: Spanopoulos, Dionysis, et al.
Publicado: (2019)

Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: ‘Multimorbidity and SARS-CoV-2 infection in UK Biobank’ (Chudasama et al.)
por: Chudasama, Yogini V, et al.
Publicado: (2020)

Trends in Splenectomy: Where Does Laparoscopy Stand?
por: Matharoo, Gurdeep S., et al.
Publicado: (2014)

Oncotype DX: Where Does It Stand in India?
por: Batra, Atul, et al.
Publicado: (2019)

Long terms trends of multimorbidity and association with physical activity in older English population
por: Dhalwani, Nafeesa N., et al.
Publicado: (2016)

Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
por: Yates, Thomas, et al.
Publicado: (2021)

Safety of antidepressants in a primary care cohort of adults with obesity and depression
por: Morriss, Richard, et al.
Publicado: (2021)

Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT
por: Biddle, Stuart J. H., et al.
Publicado: (2017)

Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals
por: Chudasama, Yogini V., et al.
Publicado: (2020)

Toe gaps and their assessment in footwear for people with diabetes: a narrative review
por: Jones, Petra, et al.
Publicado: (2020)

Vaccine for Diabetes—Where Do We Stand?
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2022)

The Convalescent Plasma Craze! Where Does India Stand?
por: Priyadarsini, Arcot J., et al.
Publicado: (2021)

Associations of reallocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: a cross-sectional analysis of adults at risk of type 2 diabetes
por: Edwardson, Charlotte L, et al.
Publicado: (2017)

Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
por: Lawson, Claire A, et al.
Publicado: (2021)

Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study
por: Chudasama, Yogini V., et al.
Publicado: (2020)

Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes)
por: Wilmot, Emma G, et al.
Publicado: (2011)

Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on?
por: Carter, Patrice, et al.
Publicado: (2012)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies, Melanie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_72fj2h3u6srer5pgqd60k7s8kt